Department of Heart and Vessels, Careggi Hospital, Florence, Italy.
Ann Thorac Surg. 2012 May;93(5):1469-76. doi: 10.1016/j.athoracsur.2011.11.025. Epub 2012 Feb 17.
Limited information exists about the real impact of the etiology of shock on early and late outcome after emergency surgery in acute native mitral valve endocarditis (ANMVE). This multicenter study analyzed the impact of the etiology of shock on early and late outcome in patients with ANMVE.
Data were collected in eight institutions. Three hundred-seventy-nine ANMVE patients undergoing surgery on an emergency basis between May 1991 and December 2009 were eligible for the study. According to current criteria used for the differential diagnosis of shock, patients were retrospectively assigned to one of three groups: group 1, no shock (n=154), group 2, cardiogenic shock (CS [n=118]), and group 3, septic shock (SS [n=107]). Median follow-up was 69.8 months.
Early mortality was significantly higher in patients with SS (p<0.001). At multivariable logistic regression analysis, compared with patients with CS, patients with SS had more than 3.8 times higher risk of death. That rose to more than 4 times versus patients without shock. In addition, patients with SS had 4.2 times and 4.3 times higher risk of complications compared with patients with CS and without shock, respectively. Sepsis was also an independent predictor of prolonged artificial ventilation (p=0.04) and stroke (p=0.003) whereas CS was associated with a higher postoperative occurrence of low output syndrome and myocardial infarction (p<0.001). No difference was detected between groups in 18-year survival, freedom from endocarditis, and freedom from reoperation.
Our study suggests that emergency surgery for ANMVE in patients with CS achieved satisfactory early and late results. In contrast, the presence of SS was linked to dismal early prognosis. Our findings need to be confirmed by further larger studies.
在急诊手术治疗急性原发性二尖瓣心内膜炎(ANMVE)中,关于病因引起的休克对早期和晚期结果的实际影响的信息有限。这项多中心研究分析了 ANMVE 患者病因性休克对早期和晚期结果的影响。
数据收集于 8 家机构。1991 年 5 月至 2009 年 12 月,共有 379 例因 ANMVE 而行急诊手术的患者符合研究条件。根据目前用于休克鉴别诊断的标准,将患者回顾性地分为三组:组 1,无休克(n=154),组 2,心源性休克(CS [n=118]),组 3,感染性休克(SS [n=107])。中位随访时间为 69.8 个月。
SS 患者的早期死亡率显著更高(p<0.001)。多变量逻辑回归分析显示,与 CS 患者相比,SS 患者的死亡风险高 3.8 倍以上。与无休克患者相比,这一数字上升至 4 倍以上。此外,与 CS 患者和无休克患者相比,SS 患者发生并发症的风险分别高 4.2 倍和 4.3 倍。感染也是延长人工通气(p=0.04)和中风(p=0.003)的独立预测因素,而 CS 与术后低心输出综合征和心肌梗死的发生(p<0.001)相关。三组在 18 年生存率、无心内膜炎和无再次手术方面均无差异。
我们的研究表明,CS 患者的 ANMVE 急诊手术取得了满意的早期和晚期结果。相比之下,SS 的存在与不良的早期预后相关。我们的研究结果需要进一步的大规模研究来证实。